Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360; Guardant360 LDT; Guardant360 CDx; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It also offers Shield Test; Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, a suite of advanced analytical technologies to enhance the performance and clinical utility of cancer tests. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. Guardant Health, Inc. has a research collaboration agreement with the Parker Institute for Cancer Immunotherapy to study the correlation between molecular cancer biomarkers and patient response to immunotherapy treatment across various types of cancer. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
Especificación
Tipo de cuenta
CFD Trading: MetaTrader 5
CFD Trading: MetaTrader 5
Investing: Web
Comisiones
0.1%
Horario de operaciones (UTC)
Abrir ahoraCerradoCierre elApertura el
a las
-
El horario de apertura del mercado se indica según su zona horaria local
(UTC)
Abre una cuenta y comienza a invertir con Metadoro ahora. Invite a amigos y obtenga remuneración por su comercio activo. Puede obtener más información sobre el programa de afiliados en su Área Personal.
Gracias por visitarnos metadoro.com. Este sitio web es administrado por RHC Investments, que está autorizada y regulada como Agente de Inversiones por la Comisión de Servicios Financieros de Mauricio con el número de licencia C115015381. Mauricio no forma parte del marco regulatorio europeo y no está dentro del alcance (entre otros) de la Directiva sobre Mercados de Instrumentos Financieros (MiFID) II.
Al continuar, confirma que la decisión se toma de forma independiente y por iniciativa propia y exclusiva y que RHC Investments no ha realizado ninguna solicitud o recomendación.
¡Personalice la suscripción a su manera!Create a Newsletter
Customize your subscriptions the way you want!
Analytics
Get notified upon new posts
Select category
Price alerts
Detección oportuna de altibajos del mercado, fluctuaciones, etc.
Select category
Alert method
All categoriescategoriesAll instrumentsinstrumentssearchNothing found